Overview

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
To compare and evaluate the pharmacokinetic characteristics and the safety of fimasartan in hepatic impairment patients and healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Collaborators:
Kyungpook National University
Kyungpook National University Hospital
Yonsei University